Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synapse Technologies

Synapse Technologies
1992 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$15.3M LATEST DEAL AMOUNT
Description

Developer of proprietary technology to deliver therapeutic enzymes and other drugs. The company focuses on discovery, development and commercialization of transport systems for therapeutic drug delivery across the blood brain barrier and new drug targets in neurodegenerative disease.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Primary Office
  • 6660 NorthWest Marine Drive
  • Vancouver, British Columbia B6T 1Z4
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Synapse Technologies’s full profile, request a free trial.

Synapse Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Mar-2002 $15.3M 000 000.00 Completed Clinical Trials - General
1. Later Stage VC 12-Jan-2000 000 000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Synapse Technologies Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BMO Financial Group Lender/Debt Provider Minority 000 0000 000000 0
Business Development Bank of Canada Venture Capital Minority 000 0000 000000 0
FutureFund Capital Venture Capital Minority 000 0000 000000 0
GrowthWorks Venture Capital Minority 000 0000 000000 0
MDS Ventures Pacific Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Synapse Technologies Executive Team (1)

Name Title Board
Seat
Contact
Info
Z Ruttonsha Chief Executive Officer & President